Clal Insurance Enterprises Holdings Ltd / TEVA
Clal Insurance Enterprises Holdings Ltd’s Teva Pharmaceutical Inds Ltd Position
Does Clal Insurance Enterprises Holdings Ltd own Teva Pharmaceutical Inds Ltd (TEVA)? Yes — 38.45M shares worth $1.1B (+6.91% of its 13F portfolio) as of Q1 2026, up from 37.40M shares the prior filed quarter.
Position Value
$1.1B
Q1 2026
Shares
38.45M
% of Portfolio
+6.91%
Quarters Held
30
currently held
Position History TEVA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 38.45M | $1.1B | +6.91% |
| Q4 2025 | 37.40M | $1.2B | +7.56% |
| Q3 2025 | 31.49M | $633M | +4.83% |
| Q2 2025 | 32.36M | $543M | +5.34% |
| Q1 2025 | 37.79M | $578M | +5.98% |
| Q4 2024 | 38.96M | $860M | +7.75% |
| Q3 2024 | 34.54M | $621M | +5.50% |
| Q2 2024 | 32.34M | $526M | +5.50% |
| Q1 2024 | 28.79M | $406M | +4.57% |
| Q4 2023 | 32.80M | $343M | +4.49% |
| Q3 2023 | 30.61M | $312M | +4.35% |
| Q2 2023 | 31.61M | $238M | +2.85% |
| Q1 2023 | 18.84M | $161M | +2.42% |
| Q4 2022 | 18.43M | $169M | +2.53% |
| Q3 2022 | 19.41M | $155M | +2.13% |
| Q2 2022 | 18.96M | $138M | +1.84% |
| Q1 2022 | 17.54M | $168M | +1.77% |
| Q4 2021 | 17.54M | $138M | +1.50% |
| Q3 2021 | 17.66M | $172M | +1.96% |
| Q2 2021 | 15.83M | $157M | +1.79% |
| Q1 2021 | 14.41M | $166M | +1.92% |
| Q4 2020 | 14.58M | $131M | +1.79% |
| Q3 2020 | 13.91M | $125M | +2.11% |
| Q2 2020 | 16.42M | $202M | +4.01% |
| Q1 2020 | 119.6K | $13M | +13.06% |
| Q4 2019 | 48.3K | $4.9B | +5.29% |
| Q3 2019 | 2.60M | $18M | +0.44% |
| Q2 2019 | 2.60M | $24M | +0.55% |
| Q1 2019 | 3.09M | $48M | +1.19% |
| Q4 2018 | 3.78M | $58M | +1.52% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Clal Insurance Enterprises Holdings Ltd’s full portfolio or all institutional holders of TEVA.